Barclays’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-341,600
| Closed | -$198M | – | 5436 |
|
|
2025
Q4 | $198M | Buy |
341,600
+334,500
| +4,711% | +$189M | 0.05% | 287 |
|
|
2025
Q3 | $3.44M | Sell |
7,100
-300
| -4% | -$140K | ﹤0.01% | 2473 |
|
|
2025
Q2 | $3M | Buy |
+7,400
| New | +$3.09M | ﹤0.01% | 2537 |
|
|
2025
Q1 | – | Sell |
-170,000
| Closed | -$88.4M | – | 5552 |
|
|
2024
Q4 | $88.4M | Buy |
170,000
+161,500
| +1,900% | +$88.8M | 0.02% | 442 |
|
|
2024
Q3 | $5.26M | Buy |
+8,500
| New | +$5.03M | ﹤0.01% | 2058 |
|
|
2024
Q1 | – | Sell |
-17,800
| Closed | -$9.45M | – | 5363 |
|
|
2023
Q4 | $9.45M | Buy |
17,800
+2,400
| +16% | +$1.16M | ﹤0.01% | 1555 |
|
|
2023
Q3 | $7.8M | Sell |
15,400
-2,800
| -15% | -$1.49M | ﹤0.01% | 1103 |
|
|
2023
Q2 | $9.5M | Buy |
+18,200
| New | +$9.82M | 0.01% | 1009 |
|
|
2023
Q1 | – | Sell |
-27,800
| Closed | -$15.3M | – | 5349 |
|
|
2022
Q4 | $15.3M | Sell |
27,800
-7,600
| -21% | -$4.03M | 0.01% | 1014 |
|
|
2022
Q3 | $18M | Buy |
+35,400
| New | +$19.8M | 0.02% | 643 |
|
|
2022
Q1 | – | Sell |
-1,900
| Closed | -$1.27M | – | 5602 |
|
|
2021
Q4 | $1.27M | Hold |
1,900
| – | – | ﹤0.01% | 2674 |
|
|
2021
Q3 | $1.09M | Hold |
1,900
| – | – | ﹤0.01% | 2740 |
|
|
2021
Q2 | $958K | Hold |
1,900
| – | – | ﹤0.01% | 2687 |
|
|
2021
Q1 | $867K | Sell |
1,900
-31,200
| -94% | -$14.9M | ﹤0.01% | 2862 |
|
|
2020
Q4 | $15.4M | Buy |
33,100
+6,400
| +24% | +$3M | 0.01% | 948 |
|
|
2020
Q3 | $11.8M | Buy |
26,700
+6,000
| +29% | +$2.48M | 0.01% | 963 |
|
|
2020
Q2 | $7.5M | Sell |
20,700
-25,500
| -55% | -$8.55M | 0.01% | 1113 |
|
|
2020
Q1 | $13.1M | Buy |
46,200
+18,700
| +68% | +$5.9M | 0.01% | 854 |
|
|
2019
Q4 | $8.93M | Buy |
27,500
+6,700
| +32% | +$2.03M | 0.01% | 1489 |
|
|
2019
Q3 | $6.06M | Buy |
20,800
+16,400
| +373% | +$4.7M | ﹤0.01% | 1681 |
|
|
2019
Q2 | $1.29M | Sell |
4,400
-3,200
| -42% | -$881K | ﹤0.01% | 3420 |
|
|
2019
Q1 | $2.08M | Sell |
7,600
-42,600
| -85% | -$10.6M | ﹤0.01% | 2529 |
|
|
2018
Q4 | $11.2M | Buy |
50,200
+13,700
| +38% | +$3.21M | 0.01% | 1081 |
|
|
2018
Q3 | $8.91M | Sell |
36,500
-7,500
| -17% | -$1.73M | 0.01% | 1336 |
|
|
2018
Q2 | $9.11M | Buy |
44,000
+16,300
| +59% | +$3.46M | 0.01% | 1285 |
|
|
2018
Q1 | $5.72M | Sell |
27,700
-32,300
| -54% | -$6.78M | ﹤0.01% | 1542 |
|
|
2017
Q4 | $11.4M | Buy |
60,000
+43,100
| +255% | +$8.26M | 0.01% | 1117 |
|
|
2017
Q3 | $3.2M | Buy |
16,900
+100
| +0.6% | +$18.1K | ﹤0.01% | 1889 |
|
|
2017
Q2 | $2.93M | Sell |
16,800
-20,800
| -55% | -$3.49M | ﹤0.01% | 1908 |
|
|
2017
Q1 | $5.78M | Sell |
37,600
-40,600
| -52% | -$6.21M | 0.01% | 1231 |
|
|
2016
Q4 | $11M | Buy |
78,200
+48,000
| +159% | +$7.08M | 0.01% | 897 |
|
|
2016
Q3 | $4.8M | Buy |
30,200
+5,000
| +20% | +$770K | 0.01% | 1331 |
|
|
2016
Q2 | $3.72M | Buy |
25,200
+19,200
| +320% | +$2.83M | ﹤0.01% | 1520 |
|
|
2016
Q1 | $846K | Sell |
6,000
-99,200
| -94% | -$13.3M | ﹤0.01% | 2671 |
|
|
2015
Q4 | $14.8M | Sell |
105,200
-2,700
| -3% | -$360K | 0.02% | 704 |
|
|
2015
Q3 | $13.2M | Sell |
107,900
-300
| -0.3% | -$39.1K | 0.02% | 795 |
|
|
2015
Q2 | $14M | Buy |
108,200
+3,200
| +3% | +$417K | 0.02% | 836 |
|
|
2015
Q1 | $14.1M | Buy |
105,000
+64,500
| +159% | +$8.32M | 0.02% | 885 |
|
|
2014
Q4 | $5.06M | Sell |
40,500
-18,100
| -31% | -$2.2M | ﹤0.01% | 1699 |
|
|
2014
Q3 | $7.09M | Buy |
58,600
+35,200
| +150% | +$4.28M | 0.01% | 1461 |
|
|
2014
Q2 | $2.76M | Sell |
23,400
-91,000
| -80% | -$10.7M | ﹤0.01% | 2293 |
|
|
2014
Q1 | $13.7M | Sell |
114,400
-1,003,100
| -90% | -$119M | 0.02% | 929 |
|
|
2013
Q4 | $124M | Buy |
1,117,500
+82,300
| +8% | +$8.18M | 0.13% | 118 |
|
|
2013
Q3 | $95.2M | Buy |
1,035,200
+30,900
| +3% | +$2.79M | 0.11% | 126 |
|
|
2013
Q2 | $85M | Buy |
+1,004,300
| New | +$83.6M | 0.11% | 139 |
|
Other funds holding TMO
VCM
Barclays's TMO Position: Q1 2026 in Review
Barclays increased its Thermo Fisher Scientific (TMO) stake by 10% in Q1 2026, buying an estimated $94.6M and bringing the position to 1,844,083 shares worth $906M. The position accounts for 0.22% of the portfolio, ranked #65.
Barclays first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.06B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Barclays held 1,844,083 shares of Thermo Fisher Scientific worth $906M as of Q1 2026.
- Barclays bought 174,349 Thermo Fisher Scientific shares in Q1 2026, an estimated $94.6M.
- Thermo Fisher Scientific made up 0.22% of Barclays's portfolio in Q1 2026, its #65 holding.
- Barclays first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Barclays's Thermo Fisher Scientific position peaked at $1.06B in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.